Log in
Enquire now
‌

Augustine Therapeutics

Augustine Therapeutics is a neuromuscular drug developer founded in 2019.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
CEO
Gerhard Koenig
Gerhard Koenig
Country
Belgium
Belgium
Email Address
info@augustinetx.com
Founded Date
2019
Headquarters
Leuven
Leuven
Industry
Pharmaceutical industry
Pharmaceutical industry
Therapeutics
Therapeutics
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Investors
Novo Holdings
Novo Holdings
Newton BioCapital
Newton BioCapital
Gemma Frisius Fund
Gemma Frisius Fund
Jeito Capital
Jeito Capital
Asabys Partners
Asabys Partners
Eli Lilly
Eli Lilly
VIB
VIB
‌
PMV
V-Bio Ventures
V-Bio Ventures
Latest Funding Round Date
March 24, 2025
Latest Funding Round Amount (USD)
84,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/augustine-therapeutics
Location
Belgium
Belgium
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
102,000,000
Official Website
augustinetx.com

Find more companies like Augustine Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.